These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10757413)

  • 1. Design, synthesis and evaluation of N-basic substituted 3-hydroxypyridin-4-ones: orally active iron chelators with lysosomotrophic potential.
    Liu ZD; Khodr HH; Lu SL; Hider RC
    J Pharm Pharmacol; 2000 Mar; 52(3):263-72. PubMed ID: 10757413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
    Rai BL; Dekhordi LS; Khodr H; Jin Y; Liu Z; Hider RC
    J Med Chem; 1998 Aug; 41(18):3347-59. PubMed ID: 9719587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values.
    Liu ZD; Piyamongkol S; Liu DY; Khodr HH; Lu SL; Hider RC
    Bioorg Med Chem; 2001 Mar; 9(3):563-73. PubMed ID: 11310590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of aromatic ester prodrugs of 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41) as orally active iron chelators.
    Liu ZD; Liu DY; Lu SL; Hider RC
    Arzneimittelforschung; 2000 May; 50(5):461-70. PubMed ID: 10858874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
    Dobbin PS; Hider RC; Hall AD; Taylor PD; Sarpong P; Porter JB; Xiao G; van der Helm D
    J Med Chem; 1993 Aug; 36(17):2448-58. PubMed ID: 8355246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potential.
    Liu ZD; Liu DY; Lu SL; Hider RC
    J Pharm Pharmacol; 1999 May; 51(5):555-64. PubMed ID: 10411215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, physicochemical characterization, and biological evaluation of 2-(1'-hydroxyalkyl)-3-hydroxypyridin-4-ones: novel iron chelators with enhanced pFe(3+) values.
    Liu ZD; Khodr HH; Liu DY; Lu SL; Hider RC
    J Med Chem; 1999 Nov; 42(23):4814-23. PubMed ID: 10579844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidentate pyridinones inhibit the metabolism of nontransferrin-bound iron by hepatocytes and hepatoma cells.
    Chua AC; Ingram HA; Raymond KN; Baker E
    Eur J Biochem; 2003 Apr; 270(8):1689-98. PubMed ID: 12694182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo iron mobilisation evaluation of hydroxypyridinones in 59Fe-ferritin-loaded rat model.
    Liu ZD; Lu SL; Hider RC
    Biochem Pharmacol; 1999 Mar; 57(5):559-66. PubMed ID: 9952320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelators.
    Liu ZD; Kayyali R; Hider RC; Porter JB; Theobald AE
    J Med Chem; 2002 Jan; 45(3):631-9. PubMed ID: 11806714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of a novel oral iron chelator: 1-(N-Acetyl-6-Aminohexyl)-3-Hydroxy-2-Methylpyridin-4-one.
    Pangjit K; Banjerdpongchai R; Phisalaphong C; Fucharoen S; Xie YY; Lu ZD; Hider RC; Srichairatanakool S
    J Pharm Pharmacol; 2015 May; 67(5):703-13. PubMed ID: 25627251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
    Kontoghiorghes GJ; Sheppard L; Hoffbrand AV; Charalambous J; Tikerpae J; Pippard MJ
    J Clin Pathol; 1987 Apr; 40(4):404-8. PubMed ID: 3584483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin-4-ones CP20 and CP94.
    Chenoufi N; Hubert N; Loréal O; Morel I; Pasdeloup N; Cillard J; Brissot P; Lescoat G
    J Hepatol; 1995 Aug; 23(2):166-73. PubMed ID: 7499788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of fluorinated iron chelators for metabolic study and brain uptake.
    Ma Y; Roy S; Kong X; Chen Y; Liu D; Hider RC
    J Med Chem; 2012 Mar; 55(5):2185-95. PubMed ID: 22339047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic 3-hydroxypyridin-4-ones: potential antimalarial agents.
    Dehkordi LS; Liu ZD; Hider RC
    Eur J Med Chem; 2008 May; 43(5):1035-47. PubMed ID: 17869385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amido-3-hydroxypyridin-4-ones as iron(III) ligands.
    Piyamongkol S; Ma YM; Kong XL; Liu ZD; Aytemir MD; van der Helm D; Hider RC
    Chemistry; 2010 Jun; 16(21):6374-81. PubMed ID: 20397153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats.
    Zanninelli G; Choudury R; Loréal O; Guyader D; Lescoat G; Arnaud J; Verna R; Cosson B; Singh S; Hider RC; Brissot P
    J Hepatol; 1997 Jul; 27(1):176-84. PubMed ID: 9252093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging understanding of the advantage of small molecules such as hydroxypyridinones in the treatment of iron overload.
    Hider RC; Liu ZD
    Curr Med Chem; 2003 Jun; 10(12):1051-64. PubMed ID: 12678676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel diaroylhydrazine ligands as iron chelators: coordination chemistry and biological activity.
    Bernhardt PV; Chin P; Sharpe PC; Wang JY; Richardson DR
    J Biol Inorg Chem; 2005 Nov; 10(7):761-77. PubMed ID: 16193304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and physicochemical assessment of novel 2-substituted 3-hydroxypyridin-4-ones, novel iron chelators.
    Moridani MY; Tilbrook GS; Khodr HH; Hider RC
    J Pharm Pharmacol; 2002 Mar; 54(3):349-64. PubMed ID: 11902801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.